Gros, Louis
Yip, Rowena
Zhu, Yeqing
Li, Pengfei
Paksashvili, Natela
Sun, Qi
Yankelevitz, David F.
Henschke, Claudia I.
Funding for this research was provided by:
Foundation Nelia and Amadeo Barletta
Article History
Received: 2 August 2024
Accepted: 14 October 2024
First Online: 2 December 2024
Declarations
:
: Dr. Yankelevitz is a named inventor on a number of patents and patent applications related to the evaluation of chest diseases including measurements of chest nodules. Dr. Yankelevitz has received financial compensation for the licensing of these patents. In addition, he is a consultant and co-owner of Accumetra, a private company developing tools to improve the quality of CT imaging. He is on the advisory board and owns equity in HeartLung, a company that develops software related to CT scans of the chest. He is on the medical advisory board of Median Technology that is developing technology related to analyzing pulmonary nodules and is on the medical advisory board of Carestream, a company that develops radiography equipment. He is also on the advisory board for LungLife AI.• Dr. Claudia Henschke is also an inventor of the patents and pending patents owned by Cornell Research Foundation (CRF). As of April 2009, she has divested herself of all royalties and other interests arising from these. She is on the medical advisory board for LungLife AI. • The other authors have no competing interests.